Pregina
Formulation
Each tablet contains:
Clomifene citrate 50 mg

Clomifene Citrate

Pregina®

Prescription Drug

Indication

Clomifene citrate is indicated for induction of ovulation in patients with persistent ovulatory dysfunction who desire pregnancy. The work-up and treatment of candidates for clomifene therapy should be supervised by physicians experienced in the management of gynecologic or endocrine disorders. Patients should be chosen for therapy with clomifene only after careful diagnostic evaluation. The work-up of the patient must begin with a careful and detailed history of menstrual and reproductive function, and a complete physical examination. It should be followed by a selective and careful laboratory investigation based on historical and physical findings.

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.